Four-Year Survival in Patients (Pts) Undergoing Liver Surgery After Neoadjuvant Triplet Hepatic Artery Infusion (Hai) and Intravenous Cetuximab (Iv-Cet) for Previously Treated and Unresectable Liver Metastases from Kras Wt Colorectal Cancer (Lm-Crc) (European Trial Optiliv, Nct00852228).

AuthID
P-00P-9YX
17
Author(s)
Smith, DM
·
Hebbar, M
·
Lepere, C
·
Focan, CNJ
·
Guimbaud, R
·
Innominato, PF
·
Carvalho, C
·
Tumolo, S
·
Truant, S
·
Castaing, D
·
Karaboue, A
·
Boige, V
·
Bouchahda, M
·
Rougier, P
·
Adam, R
1
Group Author(s)
ARTBC Int
Tipo de Documento
Abstract
Year published
2014
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 32, Número: 15
Conference
50Th Annual Meeting of the American-Society-Of-Clinical-Oncology, Date: MAY 30-JUN 03, 2014, Location: Chicago, IL, Patrocinadores: Amer Soc Clin Oncol
Indexing
Publication Identifiers
Wos: WOS:000358613203105
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.